| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |